Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 20.48% | 22.04% | 23.41% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 20.48% | 22.04% | 23.41% | |
| Cost of Revenue | -- | 19.07% | 23.57% | 17.62% | |
| Gross Profit | -- | 20.75% | 21.76% | 24.54% | |
| SG&A Expenses | -- | 18.85% | 18.28% | 18.82% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 19.38% | 19.31% | 17.97% | |
| Operating Income | -- | 27.34% | 41.47% | 71.14% | |
| Income Before Tax | -- | -49.24% | -76.30% | -265.24% | |
| Income Tax Expenses | -- | -0.97% | 23.05% | 26.84% | |
| Earnings from Continuing Operations | -- | -46.08% | -73.63% | -248.96% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -46.08% | -73.63% | -248.96% | |
| EBIT | -- | 27.34% | 41.47% | 71.14% | |
| EBITDA | -- | 23.24% | 33.99% | 56.06% | |
| EPS Basic | -- | -44.24% | -66.02% | -222.82% | |
| Normalized Basic EPS | -- | 203.58% | 88.97% | 88.97% | |
| EPS Diluted | -- | -42.79% | -62.63% | -211.52% | |
| Normalized Diluted EPS | -- | 198.99% | 86.88% | 86.88% | |
| Average Basic Shares Outstanding | -- | 17.62% | 13.90% | 10.16% | |
| Average Diluted Shares Outstanding | -- | 20.10% | 15.38% | 10.15% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |